FOLLOWING ECIL 4
European Conference on Infections in Leukemia. European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: summary of ECIL-4 (2011).
S. Matthes-Martin, T. Feuchtinger, P.J. Shaw, D. Engelhard, H.H. Hirsch, C. Cordonnier, P. Ljungman, on behalf of the fourth European Conference on Infections in Leukemia (ECIL).
Transpl Infect Dis 2012: 14: 555–563.
Fourth European Conference on Infections in Leukaemia (ECIL-4): Guidelines for Diagnosis and Treatment of Human Respiratory Syncytial Virus, Parainfluenza Virus, Metapneumovirus, Rhinovirus, and Coronavirus.
Hans H. Hirsch, Rodrigo Martino, Katherine N. Ward, Michael Boeckh, Hermann Einsele, and Per Ljungman
Clinical Infectious Diseases Advance Access published November 1, 2012.
European guidelines for prevention and management of influenza in hematopoietic stem cell transplantation and leukaemia patients: summary of ECIL-4 (2011).
D. Engelhard, B. Mohty, R. de la Camara, C. Cordonnier, P. Ljungman., on behalf of ECIL, a joint venture of EBMT, EORTC, ICHS and ELN.
Transpl Infect Dis 2013: 0: 1–14
The role of antibiotic stewardship in limiting antibacterial resistance among hematology patients.
Gyssens IC, Kern WV, Livermore D, on behalf of ECIL-4, a joint venture of EBMT, EORTC, ICHS and ESGICH of ESCMID,
Haematologica 2013, 98 (12), 1821-5
European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia.
D Averbuch, C Orasch, C Cordonnier, D M. Livermore, M Mikulska, C Viscoli, I C. Gyssens, W Kern, G Klyasova, O Marchetti, D Engelhard, M Akova, on behalf of ECIL4, a joint venture of EBMT, EORTC, ICHS, ESGICH/ESCMID and ELN.
Haematologica 2013: 98 (12): 1826-35
Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients - guidelines of the 4th European Conference on Infections in Leukemia.
D Averbuch, C Cordonnier, D M. Livermore, M Mikulska, C Orasch, C Viscoli, I C. Gyssens, W Kern, G Klyasova, O Marchetti, D Engelhard, M Akova, on behalf of ECIL4, a joint venture of EBMT, EORTC, ICHS, ESGICH/ESCMID and ELN.
Haematologica 2013: 98 (12): 1836-47
Aetiology and resistance in bacteraemias among adult and paediatric haematology and cancer patients.
Mikulska M, Viscoli C, Orasch C, Livermore DM, Averbuch D, Cordonnier C, Akova M, for the Fourth European Conference on Infections in Leukemia Group (ECIL-4), a joint venture of EBMT, EORTC, ICHS, ELN and ESGICH/ESCMID.
J Infect. 2013 Dec 24. [Epub ahead of print]
Fourth European Conference on Infections in Leukaemia(ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation.
Groll AH, Castagnola E, Cesaro S, Dalle JH, Engelhard D, Hope W, Roilides E, Jan Styczynski, Adilia Warris, and Lehrnbecher T.
Lancet Oncol 2014; 15: e327–40.
The Lancet Oncology
Discontinuation of empirical antibiotic therapy in neutropenic leukaemia patients with fever of unknown origin is ethical.
Orasch C, Averbuch D, Mikulska M, Cordonnier C, Livermore DM, Gyssens IC, Klyasova G, Engelhard D, Kern W, Viscoli C, Akova M, Marchetti O; for the 4th European Conference on Infections in Leukemia.
Clin Microbiol Infect 2015; 21: e25–e27
